Adenosine A_2A agonists in development for the treatment of inflammation

Bibliography

• ZIMMERMANN H: Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch. Pharmacol (2000) 362:299–309.
   PubMed Web of Science ®Google Scholar
• DUN WIDDIE TV, DIAO L, PROCTOR WR: Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus. I Neurosci. (1997) 17:7673–7682.
   Google Scholar
• HUANG QQ, YAO SY, RITZEL MW, PATERSON AR, CASS CE, YOUNG JD: Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. J. Biol. Chem. (1994) 269:17757–17760.
   PubMed Web of Science ®Google Scholar
• WILLIAMS TC, JARVIS SM: Multiple sodium-dependent nucleoside transport systems in bovine renal brush-border membrane vesicles. Biochem. J. (1991) 274\(Part 1):27–33.
   Google Scholar
• ANDERSON CM, XIONG W, YOUNG JD, CASS CE, PARKINSON FE: Demonstration of the existence of mRNAs encoding N1/cif and N2/cit sodium/ nucleoside cotransporters in rat brain. Brain Res. Mol. Brain Res. (1996) 42:358–361.
   PubMedGoogle Scholar
• RUDOLPHI KA, SCHUBERT P, PARKINSON FE, FREDHOLM BB: Adenosine and brain ischemia. Cerebrovasc. Bran] Metab. Rev (1992) 4:346–369.
   PubMedGoogle Scholar
• LATINI S, BORDONI F, PEDATA F, CORRADETTI R: Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices. BE J. Pharmacol (1999) 127:729–739.
   PubMed Web of Science ®Google Scholar
• VIZI E, HUSZAR E, CSOMA Z et al: Plasma adenosine concentration increases during exercise: a possible contributing factor in exercise-induced bronchoconstriction in asthma../. Allergy Immunol. (2002) 109:446–448.
   PubMed Web of Science ®Google Scholar
• SPYCHALA J, DATTA NS, TAKABAYASHI K et al: Cloning of human adenosine kinase cDNA: sequence similarity to microbial ribokinases and fructokinases. Proc. Natl. Acad. Sri. USA (1996) 93:1232–1237.
   PubMed Web of Science ®Google Scholar
• ARCH JR, NEWSHOLME EA: Activities and some properties of 5'-nucleotidase, adenosine kinase and adenosine deaminase in tissues from vertebrates and invertebrates in relation to the control of the concentration and the physiological role of adenosine. Biochem. J. (1978) 174:965–977.
   PubMed Web of Science ®Google Scholar
• LLOYD HG, FREDHOLM BB: Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices. Neurochem. Int. (1995) 26:387–395.
   PubMed Web of Science ®Google Scholar
• LINDEN J: Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Ann. Rev Pharmacol Toxicol. (2001) 41:775–787.
   PubMed Web of Science ®Google Scholar
• •Review of the functional effects of AR activation.
   Google Scholar
• FREDHOLM BB, IJZERMAN AP, JACOBSON KA, KLOTZ KN, LINDEN J: International Union of Pharmacology XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev (2001) 53:527–552.
   Google Scholar
• ••Classification of AR subtypes.
   Google Scholar
• MOSER GH, SCHRADER J, DEUSSEN A: Turnover of adenosine in plasma of human and dog blood. Am. J. Physiol (1989) 256:C799–C806.
   PubMed Web of Science ®Google Scholar
• CRONSTEIN BN: Adenosine, an endogenous anti-inflammatory agent. Appl. Physic] (1994) 76:5–13.
   PubMed Web of Science ®Google Scholar
• LAPPAS CM, RIEGER JM, LINDEN J: A2A adenosine receptor induction inhibits IFN-y production in murine CD4' T cells. Immunol. (2005) 174:1073–1080.
   Web of Science ®Google Scholar
• OHTA A, SITKOVSKY M: Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature (2001) 414:916–920.
   PubMed Web of Science ®Google Scholar
• •Seminal study indicating that no other mechanism for limiting inflammation can fully compensate for the loss of A2AAR-mediated tissue protection from inflammation.
   Google Scholar
• SULLIVAN GW, LINDEN J, HEWLETT EL, CARPER HT, HYLTON JB, MANDELL GL: Adenosine and related compounds counteract tumor necrosis factor-a inhibition of neutrophil migration: implication of a novel cyclic AMP-independent action on the cell surface. J. Immunol (1990) 145:1537–1544.
   PubMed Web of Science ®Google Scholar
• SULLIVAN GW, RIEGER JM, SCHELD WM, MacDONALD TL, LINDEN J: Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists. BE J. Pharmacol (2001) 132:1017–1026.
   PubMed Web of Science ®Google Scholar
• •Demonstrates a cAMP-mediated pathway of fii2AAR signalling in neutrophils.
   Google Scholar
• SULLIVAN GW, LEE DD, ROSS WG et al.: Activation of A2A adenosine receptors inhibits expression of a4/131 integrin (very late antigen-4) on stimulated human neutrophils. I Leukoc. Biol. (2004) 75:127–134.
   PubMed Web of Science ®Google Scholar
• HUTCHISON AJ, WEBB RL, OEI HH, GHAI GR, ZIMMERMAN MB, WILLIAMS M: CGS-21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity Pharmacol Exp. Ther. (1989) 251:47–55.
   Google Scholar
• CRISTALLI G, ELEUTERI A, VITTORI S, VOLPHINI R, LOHSE MJ, KLOTZ KN: 2-Alkynyl derivatives of adenosine and adenosine-5'-N-ethyluronamide as selective agonists at A2 adenosine receptors. J. Med. Chem. (1992) 35:2363–2368.
   PubMed Web of Science ®Google Scholar
• MARTIN PL, BARRETT RJ, LINDEN J, ABRAHAM WM: Pharmacology of 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470), a novel, short acting adenosine A2A receptor agonist that produces selective coronary vasodilation. Drug Bevel. Res. (1997) 40:313–324.
   Web of Science ®Google Scholar
• JAESCHKE H, BAUTISTA AP, SPOLARICS Z, SPITZER JJ: Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats. J. Leukoc. Biol. (1992) 52:377–382.
   PubMed Web of Science ®Google Scholar
• CHEN LY, NICHOLS WW, HENDRICKS J, MEHTA JL: Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis. Am. Heart J. (1995) 129:211–218.
   PubMed Web of Science ®Google Scholar
• THOMAS EL, GRISHAM MB, JEFFERSON MM: Cytotoxicity of chloramines. Methods Enzymol (1986) 132:585–593.
   PubMedGoogle Scholar
• WEISS SJ: Tissue destruction by neutrophils. N Engl. I Med. (1989) 320:365–376.
   PubMed Web of Science ®Google Scholar
• BADWEY JA, KARNOVSKY ML: Active oxygen species and the functions of phagocytic leukocytes. Ann. Rev Biochem. (1980) 49:695–726.
   PubMed Web of Science ®Google Scholar
• VARANI K, GESSI S, DIONISOTTI S, ONGINI E, BOREA PA: [31-1]-SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes. Br. J. Pharmacol (1998) 123:1723–1731.
   PubMed Web of Science ®Google Scholar
• RIEGER JM, BROWN ML, SULLIVAN GW, LINDEN J, MacDONALD TL: Design, synthesis, and evaluation of novel A2A adenosine receptor agonists. J. Med. Chem. (2001) 44:531–539.
   PubMed Web of Science ®Google Scholar
• THIBAULT N, BURELOUT C, HARBOUR D, BORGEAT P, NACCACHE PH, BOURGOIN SG: Occupancy of adenosine A2a receptors promotes fIVILP-induced cyclic AMP accumulation in human neutrophils: impact on phospholipase D activity and recruitment of small GTPases to membranes. J. Leukoc. Biol. (2002) 71:367–377.
   PubMed Web of Science ®Google Scholar
• CRONSTEIN BN, KRAMER SB, ROSENSTEIN ED, KORCHAK HM, WEISSMANN G, HIRSCHHORN R: Occupancy of adenosine receptors raises cyclic AMP alone and in synergy with occupancy of chemoattractant receptors and inhibits membrane depolarization. Biochem. J. (1988) 252:709–715.
   PubMed Web of Science ®Google Scholar
• CRONSTEIN BN, HAINES KA, KOLASINSKI S, REIBMAN J: Occupancy of G-linked receptors uncouples chemoattractant receptors from their stimulus-transduction mechanisms in the neutrophil. Blood (1992) 80:1052–1057.
   PubMed Web of Science ®Google Scholar
• CRONSTEIN BN, DAGUMA L, NICHOLS D, HUTCHISON AJ, WILLIAMS M: The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit 02 generation, respectively. J. Chit. Invest. (1990) 85:1150–1157.
   PubMed Web of Science ®Google Scholar
• VISSER SS, THERON AJ, RAMAFI G, KER JA, ANDERSON R: Apparent involvement of the A(2A) subtype adenosine receptor in the anti-inflammatory interactions of CGS-21680, cyclopentyladenosine, and IB-MECA with human neutrophils. Biochem. Pharmacol (2000) 60:993–999.
   PubMed Web of Science ®Google Scholar
• CRONSTEIN BN, ROSENSTEIN ED, KRAMER SB, WEISSMAN G, HIRSCHHORN R: Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. j Immunol (1985) 135:1366–1371.
   Google Scholar
• ANDERSON R, GOOLAM MA, THERON AJ, RAMAFI G, FELDMAN C: Effect of rolipram and dibutyryl cyclic AMP on resequestration of cytosolic calcium in FMLP-activated human neutrophils. Br. J. Pharmacol (1998) 124:547–555.
   PubMed Web of Science ®Google Scholar
• VILLAGRASA V, NAVARRETE C, SANZ C et al.: Inhibition of phosphodiesterase IV and intracellular calcium levels in human polymorphonuclear leukocytes. Methods Enid. Exp. Clin. Pharmacol (1996) 18:239–245.
   PubMed Web of Science ®Google Scholar
• NISSEN NN, POLVERINI PJ, KOCH AE, VOLIN MV, GAMELLI RL, DI PIETRO LA: Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am. J. Pathol (1998) 152:1445–1452.
   PubMed Web of Science ®Google Scholar
• UNDERHILL DM, OZINSKY A: Toll-like receptors: key mediators of microbe detection. Curr. Opia Immunol (2002) 14:103–110.
   PubMed Web of Science ®Google Scholar
• MEANS TK, GOLENBOCK DT, FENTON MJ: Structure and function of Toll-like receptor proteins. Lai. Sci. (2000) 68:241–258.
   Google Scholar
• BARSIG J, KUSTERS S, VOGT K, VOLK HD, TIEGS G, WENDEL A: Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-a. Eur. Immunol. (1995) 25:2888–2893.
   PubMed Web of Science ®Google Scholar
• SZABO C: Alterations in nitric oxide production in various forms of circulatory shock. New Horiz. (1995) 3:2–32.
   PubMedGoogle Scholar
• XIONG M, ELSON G, LEG D, LEIBOVICH SJ: Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am. J. Pathol (1998) 153:587–598.
   PubMed Web of Science ®Google Scholar
• GAZZINELLI RT, OSWALD IP, JAMES SL, SHER A: IL-10 inhibits parasite killing and nitrogen oxide production by IFN-y-activated macrophages. J. Immunol. (1992) 148:1792–1796.
   PubMed Web of Science ®Google Scholar
• MOSMANN TR: Properties and functionsof interleukin-10. Adv. Immunol (1994) 56:1–26.
   PubMed Web of Science ®Google Scholar
• AKSAMIT RR, BACKLUND PS Jr, CANTONI GL: Chemotaxis and the synthesis of specific proteins are inhibited by 3-deazaadenosine and other adenosine analogs in a mouse macrophage cell line. J. Biol. Chem. (1983) 258:20–23.
   PubMed Web of Science ®Google Scholar
• HON WM, KHOO HE, NGOI SS, MOO CHHALA S: Effects of adenosine receptor agonists on nitric oxide release in mouse during endotoxemia. Biochem. Pharmacol (1995) 50:45–47.
   PubMed Web of Science ®Google Scholar
• LEONARD EJ, SKEEL A, CHIANG PK, CANTONI GL: The action of the adenosylhomocysteine hydrolase inhibitor, 3-deazaadenosine, on phagocytic function of mouse macrophages and human monocytes. Biochem. Biophys. Res. Commun. (1978) 84:102–109.
   PubMed Web of Science ®Google Scholar
• HASKO G, SZABO C, NEMETH ZH, KVETAN V, PASTORES SM, VIZI ES: Adenosine receptor agonists differentially regulate IL-10, TNF-a, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. (1996) 157:4634–4640.
   Google Scholar
• •Demonstrates the differential regulation of pro- and anti-inflammatory cytokine production by A2AAR agonists.
   Google Scholar
• NEMETH ZH, LEIBOVICH SJ, DEITCH EA, VIZI ES, SZABO C, HASKO G: cDNA microarray analysis reveals a nuclear factor-KB-independent regulation of macrophage function by adenosine. Pharmacol. Exp. Ther. (2003) 306:1042–1049.
   PubMed Web of Science ®Google Scholar
• MINGUET S, HUBER M, ROSENKRANZ L, SCHAMEL WW, RETH M, BRUMMER T: Adenosine and cAMP are potent inhibitors of the NF-KB pathway downstream of immunoreceptors. Eur. Immunol (2005) 35:31–41.
   PubMed Web of Science ®Google Scholar
• MAJUMDAR S, AGGARWAL BB: Adenosine suppresses activation of nuclear factor-KB selectively induced by tumor necrosis factor in different cell types. Oncogene (2003) 22:1206–1218.
   PubMed Web of Science ®Google Scholar
• TRINCHIERI G: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann. Rev Immunol (1995) 13:251–276.
   PubMed Web of Science ®Google Scholar
• GERMANN T, SZELIGA J, HESS H et al:Administration of interleukin-12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc. Nati Acad. Sci. USA (1995) 92:4823–4827.
   PubMed Web of Science ®Google Scholar
• LEONARD JP, WALDBURGER KE, GOLDMAN SJ: Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. (1995) 181:381–386.
   PubMed Web of Science ®Google Scholar
• WYSOCZA M, KUBIN M, VIEIRA LQ eta].: Interleukin-12 is required for interferon-y production and lethality in lipopolysaccharide-induced shock in mice. Eur. Immunol (1995) 25:672–676.
   Google Scholar
• HASKO G, KUHEL DG, CHEN JF et al: Adenosine inhibits IL-12 and TNF-[a] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J. (2000) 14:2065–2074.
   PubMed Web of Science ®Google Scholar
• FOSSETTA J, JACKSON J, DENO G eta].: Pharmacological analysis of calcium responses mediated by the human A3 adenosine receptor in monocyte-derived dendritic cells and recombinant cells. Mol. Pharmacol (2003) 63:342–350.
   Google Scholar
• HOFER S, IVARSSON L, STOITZNER P et al: Adenosine slows migration of dendritic cells but does not affect other aspects of dendritic cell maturation. J. Invest. Dermatol (2003) 121:300–307.
   PubMed Web of Science ®Google Scholar
• PANTHER E, IDZKO M, HEROUY Y et al: Expression and function of adenosine receptors in human dendritic cells. FASEB (2001) 15:1963–1970.
   PubMed Web of Science ®Google Scholar
• DICKENS ON JM, REEDER S, REES B, ALEXANDER S, KENDALL D: Functional expression of adenosine A2A and A3 receptors in the mouse dendritic cell line XS-106. Eur. Pharmacol (2003) 474:43–51.
   PubMed Web of Science ®Google Scholar
• LEIBOVICH SJ, CHEN JF, PINHAL-ENFIELD G et al: Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin. Am. J. Pathol (2002) 160:2231–2244.
   PubMed Web of Science ®Google Scholar
• PINHAL-ENFIELD G, RAMANATHAN M, HASKO G et al: An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am. Pathol (2003) 163:711–721.
   PubMed Web of Science ®Google Scholar
• MONTESINOS MC, DESAI A, CHEN JF et al.: Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. Am. J. Pathol (2002) 160:2009–2018.
   PubMed Web of Science ®Google Scholar
• APASOV SG, BLACKBURN MR, KELLEMS RE, SMITH PT, SITKOVSKY MV: Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling. J. Chi]. Invest. (2001) 108:131–141.
   PubMed Web of Science ®Google Scholar
• APASOV SG, SITKOVSKY MV: The extracellular versus intracellular mechanisms of inhibition of TCR-triggered activation in thymocytes by adenosine under conditions of inhibited adenosine deaminase. Int. Immunol (1999) 11:179–189.
   PubMed Web of Science ®Google Scholar
• ••Differentiates between the effects of theAR-mediated signaling and intracellular cytotoxicity of adenosine.
   Google Scholar
• HUANG S, APASOV S, KOSHIBA M, SITKOVSKY M: Role of A, extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood (1997) 90:1600–1610.
   PubMed Web of Science ®Google Scholar
• KOSHIBA M, ROSIN DL, HAYASHI N, LINDEN J, SITKOVSKY MV: Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Mol Pharmacol (1999) 55:614–624.
   Google Scholar
• ARMSTRONG JM, CHEN JF, SCHWARZCHILD MA et al: Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes: studies of cells from A2A-receptor-gene-deficient mice. Biochein. J. (2001) 354:123–130.
   PubMed Web of Science ®Google Scholar
• BUTLER JJ, MADER JS, WATSON CL, ZHANG H, BLAY J, HOSKIN DW: Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways. Cell Biochein. (2003) 89:975–991.
   PubMed Web of Science ®Google Scholar
• ZHANG H, CONRAD DM, BUTLER JJ, ZHAO C, BLAY J, HOSKIN DW: Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes: role of cyclic adenosine 3',5'-monophosphate and phosphatases. Iminunol (2004) 173:932–944.
   PubMed Web of Science ®Google Scholar
• BORGER P, KAUFFMAN HF, POSTMA DS, VELLENGA E: Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway. Blood (1996) 87:691–698.
   PubMed Web of Science ®Google Scholar
• NOVAK TJ, ROTHENBERG EV: cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc. Natl. Acad. ScL USA (1990) 87:9353–9357.
   PubMed Web of Science ®Google Scholar
• SIEGEL MD, ZHANG DH, RAY P, RAY A: Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLEO elements. Biol. Chem. (1995) 270:24548–24555.
   Web of Science ®Google Scholar
• SUBERVILLE S, BELLOCQ A, FOUQUERAY B et al: Regulation of interleukin-10 production by 0-adrenergic agonists. Eur. Immunol (1996) 26:2601–2605.
   PubMed Web of Science ®Google Scholar
• ZIDEK Z: Adenosine - cyclic AMP pathways and cytokine expression. Eur. Cytokine Netw. (1999) 10:319–328.
   PubMed Web of Science ®Google Scholar
• KOSHIBA M, KOJIMA H, HUANG S, APASOV S, SITKOVSKY MV: Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells. J. Biol. Chem. (1997) 272:25881–25889.
   PubMed Web of Science ®Google Scholar
• APASOV S, CHEN JF, SMITH P, SITKOVSKY M: A (2A) receptor dependent and A(2A) receptor independent effects of extracellular adenosine on murine thymocytes in conditions of adenosine deaminase deficiency. Blood (2000) 95:3859–3867.
   PubMed Web of Science ®Google Scholar
• MURAKAMI S, HASHIKAWA T, SAHO T et al: Adenosine regulates the IL-10-induced cellular functions of human gingival fibroblasts. Int. Immunol (2001) 13:1533–1540.
   PubMed Web of Science ®Google Scholar
• FEOKTISTOV I, GOLDSTEIN AE, BIAGGIONI I: Cyclic AMP and protein kinase A stimulate Cdc42: role of A(2) adenosine receptors in human mast cells. Mol Pharmacol (2000) 58:903–910.
   PubMed Web of Science ®Google Scholar
• LINK AA, KINO T, WORTH JA et al: Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. I Immunol (2000) 164:436–442.
   PubMed Web of Science ®Google Scholar
• SCHNURR M, TOY T, SHIN A et al: Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells. Blood (2004) 103:1391–1397.
   PubMed Web of Science ®Google Scholar
• NGUYEN DK, MONTESINOS MC, WILLIAMS AJ, KELLY M, CRONSTEIN BN: TH1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells. J. Immunol (2003) 171:3991–3998.
   Web of Science ®Google Scholar
• LUKASHEV D, OHTA A, APASOV S, CHEN JF, SITKOVSKY M: Cutting edge: physiologic attenuation of proinflammatory transcription by the Gs protein-coupled A2A adenosine receptor in vivo. J. Immunol (2004) 173:21–24.
   PubMed Web of Science ®Google Scholar
• KOSHIBA M, NAKAMACHI Y, KOSAKA H, NAKAZAWA T, TSUJI G, KUMAGAI S: Modification of cytokine milieu by A2A adenosine receptor signaling-possible application for inflammatory diseases. Nucleosides Nucleotides Nucleic Acids (2004) 23:1101–1106.
   PubMed Web of Science ®Google Scholar
• CRONSTEIN BN, EBERLE MA, GRUBER HE, LEVIN RI: Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc. Natl. Acad. Sci. USA (1991) 88:2441–2445.
   PubMed Web of Science ®Google Scholar
• DAY YJ, HUANG L, McDUFFIE MJ et al.: Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. Clin. Invest (2003) 112:883–891.
   Google Scholar
• DAY YJ, MARSHALL MA, HUANG L, McDUFFIE MJ, OJUSA MD, LINDEN J: Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am. J. Physiol Castrointest. Liver Physiol (2004) 286:G285–G293.
   PubMed Web of Science ®Google Scholar
• OKUSA MD, LINDEN J, MacDONALD T, HUANG L: Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am. J. Physiol (1999) 277:F404–F412.
   PubMedGoogle Scholar
• SCHLACK W, SCHAFER M, UEBING A, SCHAFER S, BORCHARD U, THAMER V: Adenosine-A2-receptor activation at reperfusion reduces infarct size and improves myocardial wall function in dog heart. J. Cardiovasc. Pharmacol (1993) 22:89–96.
   PubMed Web of Science ®Google Scholar
• COHEN SB, GILL SS, BAER GS, LEO BM, SCHELD WM, DIDUCH DR: Reducing joint destruction due to septic arthrosis using an adenosine2A receptor agonist. Orthop. Res. (2004) 22:427–435.
   PubMed Web of Science ®Google Scholar
• FOTHERINGHAM J, MAYNE M, HOLDEN C, NATH A, GEIGER JD: Adenosine receptors control HIV-1 Tat-induced inflammatory responses through protein phosphatase. Virology (2004) 327:186–195.
   PubMed Web of Science ®Google Scholar